baber/WOPTO huggingface dataset:
Patent JP-3795925-B2 (JP)
IPC: C12N9/10
Filed: 1997-03-31
Granted: 2006-07-12
Abstract: A DNA encoding at least part of a hyaluronan synthase of human origin, particularly encoding the whole or a part of an amino acid sequence shown by SEQ ID NO: 4. A polypeptide of the hyaluronan synthase of human origin, which is encoded by the DNA, may have a substitution, deletion or insertion of one or more amino acid residues that does not substantially lower an activity of synthesizing hyaluronan. A polypeptide of the hyaluronan synthase of human origin or a part thereof encoded by the DNA is also provided.
Patent ES-2380477-B2 (ES)
Title: Procedimiento de obtención de "25-hidroxicetona de windaus" que comprende la reacción de julia-kocienski.
Inventor: FALL DIOP YAGAMARE
IPC: A61K31/122
Filed: 2010-10-13
Granted: 2012-11-16
Abstract: La Vitamina D2, o ergocalciferol, es un análogo de la vitamina D. Se diferencia de la Vitamina D3 por la presencia de un doble enlace trans y un grupo metilo extra en la cadena lateral. La presente invención describe un procedimiento de obtención de la 25-hidroxicetona de Grundmann-Windaus (22E,24S)-de-A,B-25-Hidroxiergost-22-en-8-ona, precursor de un extenso número de análogos de la Vitamina D2, en una ruta que aplica la reacción de Julia-Kocienski para generar el doble enlace trans y que utiliza como compuesto de partida el diol de inhoffen-Lythgoe fácilmente asequible a partir de la vitamina D2 comercial.
Patent ES-2431888-B2 (ES)
Title: Sistema automático de control para cámara hiperbárica multiplaza
Inventor: PEREZ VIDAL CARLOS
IPC: A61G10/02
Filed: 2011-12-14
Granted: 2014-04-29
Abstract: Sistema automático de control para cámara hiperbárica multiplaza.#La presente invención se refiere a un sistema de automatización de cámaras hiperbáricas multiplaza formadas por uno o más compartimentos y una o más antecámaras destinadas al movimiento de pacientes y personal médico entre compartimentos y con el exterior. El sistema automático consta de una arquitectura de control y sensorización de la cámara hiperbárica, donde el control se realiza de manera centralizada desde dos autómatas programables que actúan redundantemente. La monitorización y supervisión de los tratamientos se lleva a cabo desde interfaces de usuario instaladas en un computador y en una pantalla HMI. La invención comprende la automatización de los procedimientos y protocolos médicos y de seguridad propios de los tratamientos con oxígeno hiperbárico en este tipo de cámaras. La invención es especialmente útil porque permite la realización de múltiples tratamientos complejos simultáneos, con un seguimiento de los perfiles de presurización muy exacto, y con una mayor seguridad y confort para los pacientes.
Patent ES-2531461-B2 (ES)
Title: Procedimiento de obtención de placas de yeso laminado aligeradas con residuo de poliamida en polvo
Inventor: ALAMEDA CUENCA-ROMERO LOURDES
IPC: E04C2/02
Filed: 2013-09-16
Granted: 2015-08-11
Abstract: Procedimiento de obtención de placa de yeso laminada concebida para su utilización en la construcción, especialmente para su empleo en la realización de tabiquería interior y exterior.#La placa está realizada a partir de un compuesto consistente básicamente en yeso o escayola comercial (sulfato cálcico semihidratado) y residuos de poliamida en polvo, con la posible incorporación de aditivos y fibras. El procedimiento de preparación de placas comprende añadir al yeso o escayola en seco los residuos de poliamida, añadir agua hasta obtener una masa trabajable, amasar la mezcla hasta que el compuesto sea homogéneo, verter dicho compuesto en el bastidor que actúa de molde, dejar secar y extraer la placa del molde.#Procedimiento de obtención del producto y su uso en función de las distintas propiedades del material a partir de diferentes dosificaciones, mejorando algunas de las propiedades básicas como son la trabajabilidad, el acabado y el aislamiento térmico.
Patent ES-2478190-B2 (ES)
Title: Aplicación de ultrasonidos en procesos de vinificación
Inventor: JURADO FUENTES RICARDO
IPC: C12G1/02
Filed: 2014-03-13
Granted: 2015-01-28
Abstract: La presente invención se refiere a un procedimiento, y un equipo para la extracción de compuestos de la uva mediante ultrasonidos en los procesos de vinificación generados a través de un sonoplato acoplado a las paredes de la tubería/conducto por la que circula la uva estrujada. Extracción en la que se realiza la transferencia de los fenoles responsables del color desde la parte sólida (hollejo) hacia la líquida después del estrujado de la uva como consecuencia del fenómeno conocido como cavitación, que permite la rotura de las células del hollejo y pone a disposición del medio líquido los compuestos fenólicos responsables del color para que se integren en dicho medio líquido potenciando el color del vino.
Patent ES-2599056-B2 (ES)
Title: Dispositivo para ensayar una muestra de células
Inventor: ALBERTOS SANCHEZ PABLO
IPC: C12M1/34
Filed: 2015-07-31
Granted: 2017-07-07
Abstract: Dispositivo para ensayar una muestra de células que comprende un primer depósito (1) fijado a un bastidor (38) que se apoya en una superficie de apoyo (39), un segundo depósito (2) fijado también al bastidor (38) que se apoya en la superficie de apoyo (39), un conducto plano (3) formado por dos cristales, que comunica el primer depósito (1) y el segundo depósito (2), una cámara de presión (16), un imán (40) que se mueve al menos en paralelo al conducto plano (3), una cámara (47) que recorre el conducto plano (3) en su totalidad, un alimentador (14), un elemento de presión (15), y un microcontrolador (60) que maneja los distintos elementos del dispositivo, donde el primer depósito (1), el conducto plano (3), la cámara de presión (16) y el segundo depósito (2) forman un circuito cerrado tal que una muestra puede ser llevada a cualquier punto del circuito cerrado.
Patent AU-2001285233-B2 (AU)
Title: pRNA chimera
Inventor: GUO PEIXUAN
IPC: C12N15/00
Filed: 2001-08-23
Granted: 2006-04-27
Abstract: A circularly permuted chimeric PRNA molecule carrying a stabilized biologically active RNA, such as a ribozyme.
Patent AU-2001290389-B2 (AU)
Title: A joint arrangement for demountable structure
Inventor: FRANK MANFRED JOHANNES
IPC: A47B47/04
Filed: 2001-09-28
Granted: 2007-07-19
Abstract: A joint arrangement between adjacent edges of structural elements each including a face surface and a rear surface with a profiled edge extending between the face and rear surfaces. The profiled edge forms a shoulder spaced from both the face and rear surfaces. The joint arrangement including a recess in the front surface of each structural element. The recess being adjacent the profiled edge. An elongate joiner element having projections is included. A first projection being engaged in the recess in a first structural element and a second projection engaged in the recess of a second structural element. The elongate joiner element further including a spine located within an area between the profiled edges of the first and second structural elements. A lateral projection projects from the spine and is engaged behind the shoulder relative to the face surface of the first structural element.
Patent AU-2002308050-B2 (AU)
Title: Milieux de detection specific de staphylococcus aureus
Inventor: RE ANDREA
IPC: C12Q1/68
Filed: 2002-03-29
Granted: 2007-01-25
Abstract: The invention concerns a medium for specific detection of Staphylococcus aureus and/or discrimination between positive-coagulase Staphylococcus and negative-coagulase enabling Staphylococcus to isolate bacteria of the genus staphylococcus and identify the Staphylococcus aureus species, which use at least an enzymatic substrate, preferably a chromogenic or fluorescent agent, and still more preferably consisting of an indoxyl or naphthol base. The invention also concerns a method for identifying, and optionally counting, Staphylococcus aureus using such a medium. It consists of a Staphylococcus aureus culture medium and at least an enzymatic substrate enabling testing of an α-glucosidase activity. The invention is particularly applicable in the field of diagnosis.
Patent AU-2002341134-B2 (AU)
Title: Loop impedance meter
Inventor: BATTEN DOUGLAS WILLIAM
IPC: G01R27/16
Filed: 2002-10-24
Granted: 2007-11-29
Abstract: A loop impedance meter for testing an A.C. electrical mains supply, including an electronic control circuit for connecting a load resistance intermittently between the A.C. mains supply terminal and the earth terminal to measure the potential difference between those terminals and to provide an indication of the loop impedance of the A.C. mains supply from that potential difference, wherein the control circuit is arranged to allow a train of short pulses of current to flow through the load resistance and the loop, the pulse train beginning its sequence with a first train of pulses for preconditioning any residual circuit device (RCD) present in the loop to temporarily desensitize it, wherein the first train of pulses is followed by one or more measurement pulses, the pulses of the first train being of generally increasing width.
Patent AU-2003240638-B2 (AU)
Title: Fusion protein of HIV regulatory/accessory proteins
Inventor: FELDER EVA
IPC: A61K39/00
Filed: 2003-05-14
Granted: 2008-05-15
Abstract: The invention relates to fusion proteins comprising the amino acid sequence of at least four HIV proteins selected from Vif, Vpr, Vpu, Rev, Tat and Nef or derivatives of the amino acid sequence of one or more of said proteins, wherein the fusion protein is not processed to individual HIV proteins having the natural N and C termini. The invention further concerns nucleic acids encoding said proteins, vectors comprising said nucleic acids, and methods for producing said proteins. The fusion protein, nucleic acids and vectors are usable as vaccines for the at least partial prophylaxis against HIV infections.
Patent AU-2003267010-B2 (AU)
Title: Formulations comprising water-soluble granulates
Inventor: HAISS ELKE
IPC: C11D3/37
Filed: 2003-08-26
Granted: 2009-10-08
Abstract: The present invention relates to formulations comprising water-soluble granulates of phthalocyanine compounds, to a process for the preparation thereof, and to the use thereof in washing agent and washing agent additive formulations.
Patent AU-2003293833-B2 (AU)
Title: Combination medicament
Inventor: WEIMAR CHRISTIAN
IPC: A61K31/575
Filed: 2003-12-11
Granted: 2009-10-01
Abstract: The subject matter of this application relates to the combination of ciclesonide or an epimer thereof with R,R-formoterol or a salt, or a hydrate of a salt thereof.
Patent AU-2004242759-B2 (AU)
Title: Complement inhibitors from ticks
Inventor: NUNN MILES ANDREW
IPC: C07K14/435
Filed: 2004-06-02
Granted: 2009-11-26
Abstract: The invention relates to complement inhibitors that inhibit both the classical and alternative complement pathways. In particular, the invention relates to complement inhibitors derived from the salivary glands of haematophagous arthropods that inhibit both the classical and alternative complement pathways. The invention also relates to the use of the complement inhibitors in the treatment and prevention of diseases.
Patent AU-2004298118-B2 (AU)
Title: Adaptive FEC codeword management
Inventor: CIOFFI JOHN M
IPC: H04M1/24
Filed: 2004-12-02
Granted: 2010-03-18
Abstract: A transmission system comprises a transmission channel, a transmission error value monitor and a controller. The transmission channel is arranged to carry data between a transmitter and a receiver/decoder, each communicably interfaced with the transmission channel. The transmission error value monitor is communicably interfaced with the receiver/decoder to periodically monitor for Measured transmission Error Values MEVs of such characteristics, magnitude, and/or frequency of occurrence over time, as to represent transmission errors detected on the transmission channel. The MEVs are periodically monitored after training and initialization on the receiver/decoder. The MEVs are selected from a group comprising: a bit error rate, errored seconds, errored minutes, code violations over a fixed period of time, Signal-to-Noise Ratio (SNR) measured at the receiver/decoder, and Transmission Control Protocol and Internet Protocol (TCP/IP) throughput. The transmission error value monitor is further arranged to generate an input signal based on the transmission errors detected on the transmission channel based on the MEVs. The controller is coupled with the transmitter to receive the input signal from the transmission error value monitor and to further generate control signals that instruct the transmitter and/or the receiver/decoder coding-related components to adjust their operation by changing at least an N codeword parameter outside of an interleaver of the transmission system, wherein the N codeword parameter represents a number of bytes per data frame.
Patent AU-2005259329-B2 (AU)
Title: Novel 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17Beta-hydroxysteroid dehydrogenase type 1
Inventor: HILLISCH ALEXANDER
IPC: A61K31/56
Filed: 2005-07-04
Granted: 2011-11-10
Abstract: The invention relates to novel 2-substituted D-homo-estra-1,3,5(10)-trienes of general formula (I) wherein R<SUP>2</SUP> represents a C<SUB>1</SUB>-C<SUB>8</SUB> alkyl, a C<SUB>1</SUB>-C<SUB>8</SUB> alkyloxy group or a halogen atom, R<SUP>13</SUP> represents a hydrogen atom or a methyl group, and R<SUP>17</SUP> represents a hydrogen atom or a fluorine atom. The invention also relates to the pharmaceutically acceptable salts of said compounds, to the production thereof, and to the use of the same as medicaments for the prophylaxis and treatment of oestrogen-dependent diseases that can be influenced by the inhibition of 17ß-hydroxysteroid dehydrogenase type 1.
Patent AU-2005315416-B2 (AU)
Title: A cast article and a method of its manufacture
Inventor: PICKAVANCE JOHN NEIL
IPC: E03F5/06
Filed: 2005-12-19
Granted: 2011-04-07
Abstract: A method of manufacturing a cast article including a frame that in use of the article defines an aperture; and a further component that is in use retained moveably captive relative to the frame. The method casts the further component and respective first and second frame members, the further component and the frame members being securable together to form the article, and subsequently assembles the frame members and the further component together to form the article. A gully grate results from practicing the method.
Patent AU-2006201835-B2 (AU)
Title: Orthopaedic implants and methods for making the same
Inventor: FREDERICK PHILLIP
IPC: A61F2/30
Filed: 2006-05-02
Granted: 2012-08-30
Abstract: Orthopaedic implants, orthopaedic implant sets, and/or methods for making the same. Aspects and embodiments of the present invention may include orthopaedic implants having an elongated insertion region including 5 proximal, distal, and transition portions, wherein at least portions of at least one face each of the proximal and transition portions are defined by spaced apart constant radii of curvature. The same or other aspects and embodiments may include sets of orthopaedic implants in which proximal portions of the implants grow at different rates than distal portions of the 10 implants. The same or other aspects and embodiments may include methods for making implants and/or sets of implants by studying the geometries of differently sized bony anatomies.
Patent AU-2006203947-B2 (AU)
Title: Non-irritating compositions containing zinc salts
Inventor: GAONKAR TRUPTI
IPC: A61Q17/00
Filed: 2006-01-06
Granted: 2012-05-03
Abstract: The present invention relates to methods and compositions which employ low concentrations of combinations of zinc salts to prevent the irritation of skin or mucous membranes that may be caused by therapeutic agents, by personal hygiene products, by articles such as gloves or condoms, or by various physical, chemical, mechanical, or biological irritants.
Patent AU-2006225915-B2 (AU)
Title: Process for producing continuous magnesium material
Inventor: YOSHIHIRO NAKAI
IPC: B21B3/00
Filed: 2006-02-20
Granted: 2011-06-30
Abstract: A process for producing a continuous magnesium material having excellent suitability for plastic working; and a continuous magnesium material obtained by the process. Pure magnesium or a magnesium alloy is cast and this cast material is subjected to plastic working to obtain a continuous processed material. The plastic working involves hot working which is conducted at 250°C or higher so as to result in a decrease in sectional area. Hot working yields oxides around the surfaces of the work during the working. Because of the presence of such oxides around the surface of the processed material, there is a possibility that the oxides might serve as starting points for cracks or wire breakage when the processed material is subjected to plastic working (secondary processing) such as wire drawing or forging. In this process, a surface layer of the processed material is hence removed to thereby effectively eliminate the oxides serving as starting points for cracks or wire breakage. Thus, suitability for secondary processing is improved.
Patent AU-2006262231-B2 (AU)
Title: PSMA antibody-drug conjugates
Inventor: MADDON PAUL J
IPC: A61K47/48
Filed: 2006-06-20
Granted: 2013-01-24
Abstract: This invention relates generally to antibody-drag conjugates (ADCs). In particular,the invention relates to ADCs which comprise an antibody or antigen-binding fragmentthereof which binds to prostate-specific membrane antigen (PSMA) and is conjugated tomonomethylauristatin norephedrine or monomethylauristatin phenylalanine. The antibody- drug conjugate has a PC-3™ cell to C4-2 or LNCaP™ cell selectivity of at least 250. Theinvention also relates, in part, to compositions of and methods of using the ADCs. Themethods provided include, for example, methods for treating a PSMA-mediated disease.
Patent AU-2006269225-B2 (AU)
Title: Sustained release pharmaceutical compositions for highly water soluble drugs
Inventor: BLEDSOE DAVID L
IPC: A61K31/165
Filed: 2006-07-07
Granted: 2011-10-06
Abstract: The present invention provides pharmaceutical compositions for controlled release of pharmaceutically active agents, especially those with a high water solubility, high dose, and/or short half-life. In addition, the present application provides methods for preparing and using such pharmaceutical compositions.
Patent AU-2006270184-B2 (AU)
Title: JNK inhibitors for the treatment of endometreosis
Inventor: SELVARAJ NATARAJA
IPC: A61K31/506
Filed: 2006-07-12
Granted: 2011-09-29
Abstract: This invention relates to a method of treating and/or preventing endometriosis comprising administering a JNK inhibitor. The JNK inhibitor can also be administered combined with a hormonal suppressor. The invention further relates to the treatment of endometriosis-related infertility
Patent AU-2006284747-B2 (AU)
Title: Method and apparatus for setting or modifying programable parameter in power driven wheelchair
Inventor: JAENKE BRUCE A
IPC: A61G5/04
Filed: 2006-08-31
Granted: 2013-05-02
Abstract: A method and apparatus for setting or modifying a programmable operating parameter associated with a power driven wheelchair is provided. In one embodiment, the method includes: a) operating a user interface device associated with a power driven wheelchair in a programming mode, b) selecting a programmable operating parameter associated with operation of the power driven wheelchair using the user interface device, c) selecting a value for the programmable operating parameter using the user interface device, and d) saving the selected value for the programmable operating parameter in a portion of a storage device associated with the power driven wheelchair using the user interface device. A method and apparatus for selecting one or more programmable parameter sets from a portable storage medium and saving the selected sets to a local storage device associated with a power driven wheelchair and vice versa is also provided.
Patent AU-2006284857-B2 (AU)
Title: Nucleotide sequences encoding insecticidal proteins
Inventor: BOGDANOVA NATALIA N
IPC: A01H5/10
Filed: 2006-08-30
Granted: 2011-11-10
Abstract: The present invention provides nucleotide sequences encoding an insecticidal protein exhibiting lepidopteran inhibitory activity, as well as a novel insecticidal protein referred to herein as a Cry1A.105 insecticide, transgenic plants expressing the insecticide, and methods for detecting the presence of the nucleotide sequences or the insecticide in a biological sample.
Patent AU-2006294645-B2 (AU)
Title: Milnacipran for the long-term treatment of fibromyalgia syndrome
Inventor: KRANZLER JAY D
IPC: A61K31/165
Filed: 2006-09-27
Granted: 2012-08-23
Abstract: The present invention is directed to methods for providing long-term treatment of fibromyalgia syndrome (FMS) by administering a dual re-uptake inhibitor to a patient with FMS. More particularly, the present invention is directed to the long-term treatment of FMS by administering a norepinephrine-serotonin reuptake inhibitor (NSRI) to a patient with FMS.
Patent AU-2006315105-B2 (AU)
Title: Crush resistant latex topcoat composition for fiber cement substrates
Inventor: KILLILEA T HOWARD
IPC: C04B41/63
Filed: 2006-11-15
Granted: 2012-02-16
Abstract: A coated fiber cement article in the form of an unattached fiber cement board substrate having a first major surface at least a portion of which is covered with a crush resistant final topcoat composition comprising a multistage latex polymer, and a method for making a crush resistant coated fiber cement article by coating a fiber cement board substrate with such a composition and stacking the coated boards.
Patent AU-2006343171-B2 (AU)
Title: Hyperbolic solar trough field system
Inventor: CAPAN RAHMI OGUZ
IPC: F24S50/20
Filed: 2006-05-05
Granted: 2011-01-06
Abstract: The subject matter of the invention of hyperbolic solar trough field system (B, II) comprises hyperbolic reflectors (20, 20m) in which the beams that come from the sun parallel, but of which the angle of incident changes at a fixed rate of 15 degrees per hour throughout the day are concentrated on the focal axis in the bottom part thereof, thermal receiver tubes (21) which extend throughout said focal axis and are at a fixed position, and side supports (23, 23') which are at a ground-fixed position on the both sides of the reflectors. The reflectors (20, 20m) are connected to the ground from at least one rotary joint (22) point such that said reflectors can rotate around the central axis of the thermal receiver tubes (21). The bottom part of hyperbolic reflectors (20, 20m) has been produced as circular sectioned such that it surrounds the thermal receiver tubes (21) somewhat, on the continuation; a hyperbola form has been given to its arms extending towards two sides. Other hyperbolic reflectors (20m) are also provided with a bigger second hyperbola form which starts from the point where said hyperbola form finishes.
Patent AU-2007216999-B2 (AU)
Title: Stable vitamin C compositions
Inventor: ISAAC THOMAS
IPC: A61K31/375
Filed: 2007-02-21
Granted: 2011-08-18
Abstract: Disclosed is a composition comprising ascorbic acid or a derivative thereof, a silicone containing compound, and an essential oil, wherein at least 50% of the initial amount of the ascorbic acid in the composition remains stable when the composition is stored for at least 1 month at room temperature. The composition can be non-aqueous.
Patent AU-2007238685-B2 (AU)
Title: Transdermal methods and systems for the delivery of anti-migraine compounds
Inventor: SEBREE TERRI B
IPC: A61N1/30
Filed: 2007-04-12
Granted: 2012-09-13
Abstract: Iontophoretic patches for the delivery of anti-migraine compounds and methods of using the patches are described.